Yehudah Gruenstein

Yehudah Gruenstein has worked in the medical laboratory field since 2009, beginning as a Clinical Laboratory Technologist at Shiel Medical Laboratory. In 2015, they moved to Celmatix as a Laboratory Supervisor and Quality Manager. In 2016, they became Laboratory Manager at Modern Diagnostic Laboratory. In 2018, they became Technical Director, Clinical Pathology at Sherman Abrams Labs. In 2019, they were appointed Chief Executive Officer at BioStone Solutions, LLC and Chief Quality Officer at LabQ Diagnostics. At Shiel Medical Laboratory, they had experience in all major laboratory departments, with extensive experience in the Chemistry, Microbiology, and Serology departments, and experience in SOPM writing using CAP guidelines.

Yehudah Gruenstein attended Hunter College from 2011 to 2012, where they earned an Advanced Certificate in Clinical Laboratory Science from the Graduate Program. Prior to that, they attended Touro University from 2005 to 2008, where they studied Biology, General.